TENX logo

Tenax Therapeutics (TENX) Net Income

Annual Net Income

-$7.71 M
+$3.34 M+30.21%

December 31, 2023


Summary


Performance

TENX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTENXprofitabilitymetrics:

Quarterly Net Income

-$3.96 M
-$384.80 K-10.76%

September 30, 2024


Summary


Performance

TENX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTENXprofitabilitymetrics:

TTM Net Income

-$14.56 M
-$1.99 M-15.82%

September 30, 2024


Summary


Performance

TENX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTENXprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TENX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.2%-4.3%-44.1%
3 y3 years+21.7%-258.0%-82.5%
5 y5 years-13.2%-258.0%-82.5%

TENX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+76.3%-258.0%at low-107.0%+55.2%
5 y5-yearat high+76.3%-258.0%+83.3%-107.0%+55.2%
alltimeall time-863.8%+82.5%-3860.5%+86.6%<-9999.0%+66.8%

Tenax Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.96 M(+10.8%)
-$14.56 M(+15.8%)
Jun 2024
-
-$3.58 M(-5.9%)
-$12.57 M(+24.4%)
Mar 2024
-
-$3.80 M(+17.8%)
-$10.10 M(+31.0%)
Dec 2023
-$7.71 M(-30.2%)
-$3.23 M(+63.6%)
-$7.71 M(+9.6%)
Sep 2023
-
-$1.97 M(+78.3%)
-$7.03 M(-11.8%)
Jun 2023
-
-$1.11 M(-21.4%)
-$7.98 M(-18.0%)
Mar 2023
-
-$1.41 M(-44.8%)
-$9.73 M(-11.9%)
Dec 2022
-$11.05 M(-66.0%)
-$2.55 M(-12.6%)
-$11.05 M(-5.7%)
Sep 2022
-
-$2.92 M(+1.9%)
-$11.71 M(-7.0%)
Jun 2022
-
-$2.86 M(+5.1%)
-$12.59 M(+10.0%)
Mar 2022
-
-$2.72 M(-15.2%)
-$11.45 M(-64.7%)
Dec 2021
-$32.47 M(+229.6%)
-$3.21 M(-15.5%)
-$32.47 M(+1.2%)
Sep 2021
-
-$3.80 M(+121.2%)
-$32.09 M(+5.2%)
Jun 2021
-
-$1.72 M(-92.8%)
-$30.52 M(-1.4%)
Mar 2021
-
-$23.75 M(+739.2%)
-$30.94 M(+214.1%)
Dec 2020
-$9.85 M(+17.4%)
-$2.83 M(+27.4%)
-$9.85 M(+0.4%)
Sep 2020
-
-$2.22 M(+3.4%)
-$9.81 M(-0.0%)
Jun 2020
-
-$2.15 M(-19.1%)
-$9.82 M(+4.1%)
Mar 2020
-
-$2.65 M(-4.9%)
-$9.43 M(+12.4%)
Dec 2019
-$8.39 M(+23.2%)
-$2.79 M(+25.5%)
-$8.39 M(+7.4%)
Sep 2019
-
-$2.22 M(+26.2%)
-$7.82 M(+9.6%)
Jun 2019
-
-$1.76 M(+8.9%)
-$7.13 M(-1.5%)
Mar 2019
-
-$1.62 M(-27.0%)
-$7.24 M(+6.2%)
Dec 2018
-$6.81 M(-22.9%)
-$2.22 M(+44.3%)
-$6.81 M(+14.7%)
Sep 2018
-
-$1.54 M(-17.8%)
-$5.94 M(+5.4%)
Jun 2018
-
-$1.87 M(+56.5%)
-$5.64 M(-16.6%)
Mar 2018
-
-$1.19 M(-11.2%)
-$6.76 M(-23.6%)
Dec 2017
-$8.84 M(-79.9%)
-$1.34 M(+8.9%)
-$8.84 M(-76.2%)
Sep 2017
-
-$1.23 M(-58.7%)
-$37.14 M(-7.6%)
Jun 2017
-
-$2.99 M(-8.8%)
-$40.18 M(-4.0%)
Mar 2017
-
-$3.28 M(-89.0%)
-$41.84 M(-4.7%)
Dec 2016
-$43.92 M(+336.3%)
-$29.65 M(+593.7%)
-$43.92 M(+207.7%)
Sep 2016
-
-$4.27 M(-7.9%)
-$14.28 M(-13.2%)
Jun 2016
-
-$4.64 M(-13.4%)
-$16.45 M(+10.8%)
Mar 2016
-
-$5.36 M(+52.1%)
-$14.84 M(-26.8%)
Dec 2015
-$10.07 M(-28.5%)
-
-
Oct 2015
-
-$3.52 M(+20.7%)
-$20.27 M(+21.0%)
Sep 2015
-
-$2.92 M(-3.8%)
-$16.75 M(-6.3%)
Jul 2015
-
-$3.03 M(-39.2%)
-$17.88 M(+5.1%)
Apr 2015
-$14.08 M(-27.9%)
-$4.99 M(+69.7%)
-$17.02 M(+41.4%)
Mar 2015
-
-$2.94 M(+2.5%)
-$12.03 M(-38.3%)
Jan 2015
-
-$2.87 M(-29.3%)
-$19.51 M(-2.4%)
Oct 2014
-
-$4.05 M(+86.7%)
-$19.99 M(+2.7%)
Jul 2014
-
-$2.17 M(-79.1%)
-$19.47 M(-0.4%)
Apr 2014
-$19.54 M(+107.5%)
-$10.41 M(+210.8%)
-$19.54 M(+77.9%)
Jan 2014
-
-$3.35 M(-5.1%)
-$10.99 M(+9.3%)
Oct 2013
-
-$3.53 M(+57.3%)
-$10.05 M(+24.4%)
Jul 2013
-
-$2.25 M(+20.8%)
-$8.07 M(-14.2%)
Apr 2013
-$9.42 M(-40.1%)
-$1.86 M(-23.0%)
-$9.42 M(-7.4%)
Jan 2013
-
-$2.41 M(+54.9%)
-$10.17 M(-32.4%)
Oct 2012
-
-$1.56 M(-56.6%)
-$15.06 M(-8.4%)
Jul 2012
-
-$3.59 M(+37.2%)
-$16.43 M(+4.6%)
Apr 2012
-$15.71 M
-$2.61 M(-64.2%)
-$15.71 M(-1.5%)
Jan 2012
-
-$7.30 M(+149.1%)
-$15.95 M(+42.5%)
DateAnnualQuarterlyTTM
Oct 2011
-
-$2.93 M(+2.1%)
-$11.19 M(+8.5%)
Jul 2011
-
-$2.87 M(+0.7%)
-$10.32 M(-1.3%)
Apr 2011
-$10.45 M(-0.6%)
-$2.85 M(+12.0%)
-$10.45 M(+0.8%)
Jan 2011
-
-$2.54 M(+24.0%)
-$10.37 M(-2.0%)
Oct 2010
-
-$2.05 M(-31.7%)
-$10.58 M(-4.8%)
Jul 2010
-
-$3.00 M(+8.5%)
-$11.11 M(+5.8%)
Apr 2010
-$10.51 M(-68.4%)
-$2.77 M(+0.5%)
-$10.51 M(-57.0%)
Jan 2010
-
-$2.75 M(+6.4%)
-$24.44 M(-18.6%)
Oct 2009
-
-$2.59 M(+8.0%)
-$30.04 M(-4.2%)
Jul 2009
-
-$2.40 M(-85.7%)
-$31.37 M(-5.6%)
Apr 2009
-$33.22 M(+394.2%)
-$16.70 M(+99.9%)
-$33.22 M(+75.3%)
Jan 2009
-
-$8.36 M(+113.6%)
-$18.95 M(+46.7%)
Oct 2008
-
-$3.91 M(-7.9%)
-$12.92 M(+30.0%)
Jul 2008
-
-$4.25 M(+74.3%)
-$9.94 M(+47.9%)
Apr 2008
-$6.72 M(+101.8%)
-$2.44 M(+4.8%)
-$6.72 M(+26.4%)
Jan 2008
-
-$2.33 M(+149.5%)
-$5.32 M(+36.9%)
Oct 2007
-
-$931.90 K(-9.3%)
-$3.88 M(+6.5%)
Jul 2007
-
-$1.03 M(-0.6%)
-$3.65 M(+9.5%)
Apr 2007
-$3.33 M(-18.1%)
-$1.03 M(+15.9%)
-$3.33 M(+3.6%)
Jan 2007
-
-$891.30 K(+28.2%)
-$3.21 M(+1.0%)
Oct 2006
-
-$695.30 K(-2.2%)
-$3.18 M(-23.6%)
Jul 2006
-
-$711.10 K(-22.4%)
-$4.17 M(+2.4%)
Apr 2006
-$4.07 M(+52.1%)
-$916.60 K(+6.5%)
-$4.07 M(+5.3%)
Jan 2006
-
-$860.50 K(-48.7%)
-$3.86 M(-0.7%)
Oct 2005
-
-$1.68 M(+173.9%)
-$3.89 M(+38.3%)
Jul 2005
-
-$612.30 K(-13.9%)
-$2.81 M(+5.2%)
Apr 2005
-$2.67 M(+18.8%)
-$710.90 K(-20.0%)
-$2.67 M(+7.5%)
Jan 2005
-
-$888.50 K(+48.1%)
-$2.49 M(+3.1%)
Oct 2004
-
-$600.00 K(+26.7%)
-$2.41 M(+6.1%)
Jul 2004
-
-$473.40 K(-9.6%)
-$2.27 M(+1.0%)
Apr 2004
-$2.25 M(+1.0%)
-$523.50 K(-35.6%)
-$2.25 M(+9.1%)
Jan 2004
-
-$813.30 K(+76.7%)
-$2.06 M(+20.4%)
Oct 2003
-
-$460.40 K(+1.9%)
-$1.71 M(-24.9%)
Jul 2003
-
-$451.90 K(+34.7%)
-$2.28 M(+2.3%)
Apr 2003
-$2.23 M(-36.1%)
-$335.50 K(-27.8%)
-$2.23 M(-42.3%)
Jan 2003
-
-$464.50 K(-54.8%)
-$3.86 M(-0.4%)
Oct 2002
-
-$1.03 M(+156.7%)
-$3.88 M(+15.0%)
Jul 2002
-
-$400.20 K(-79.7%)
-$3.37 M(-3.4%)
Apr 2002
-$3.49 M(+108.6%)
-$1.97 M(+308.6%)
-$3.49 M(+72.3%)
Jan 2002
-
-$481.50 K(-7.7%)
-$2.02 M(+3.8%)
Oct 2001
-
-$521.80 K(+0.9%)
-$1.95 M(+0.7%)
Jul 2001
-
-$517.40 K(+2.8%)
-$1.94 M(+15.8%)
Apr 2001
-$1.67 M(+83.5%)
-$503.20 K(+23.7%)
-$1.67 M(+13.0%)
Jan 2001
-
-$406.90 K(-20.0%)
-$1.48 M(+16.2%)
Oct 2000
-
-$508.40 K(+100.4%)
-$1.27 M(+32.0%)
Jul 2000
-
-$253.70 K(-18.5%)
-$965.00 K(+18.9%)
Apr 2000
-$911.30 K(+13.9%)
-$311.30 K(+55.6%)
-$811.30 K(+62.3%)
Jan 2000
-
-$200.00 K(0.0%)
-$500.00 K(+66.7%)
Oct 1999
-
-$200.00 K(+100.0%)
-$300.00 K(+200.0%)
Jul 1999
-
-$100.00 K
-$100.00 K
Apr 1999
-$800.00 K(-37.5%)
-
-
Apr 1998
-$1.28 M(-32.9%)
-
-
Apr 1997
-$1.91 M(-18.6%)
-
-
Apr 1996
-$2.35 M
-
-

FAQ

  • What is Tenax Therapeutics annual net profit?
  • What is the all time high annual net income for Tenax Therapeutics?
  • What is Tenax Therapeutics annual net income year-on-year change?
  • What is Tenax Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Tenax Therapeutics?
  • What is Tenax Therapeutics quarterly net income year-on-year change?
  • What is Tenax Therapeutics TTM net profit?
  • What is the all time high TTM net income for Tenax Therapeutics?
  • What is Tenax Therapeutics TTM net income year-on-year change?

What is Tenax Therapeutics annual net profit?

The current annual net income of TENX is -$7.71 M

What is the all time high annual net income for Tenax Therapeutics?

Tenax Therapeutics all-time high annual net profit is -$800.00 K

What is Tenax Therapeutics annual net income year-on-year change?

Over the past year, TENX annual net profit has changed by +$3.34 M (+30.21%)

What is Tenax Therapeutics quarterly net profit?

The current quarterly net income of TENX is -$3.96 M

What is the all time high quarterly net income for Tenax Therapeutics?

Tenax Therapeutics all-time high quarterly net profit is -$100.00 K

What is Tenax Therapeutics quarterly net income year-on-year change?

Over the past year, TENX quarterly net profit has changed by -$161.70 K (-4.26%)

What is Tenax Therapeutics TTM net profit?

The current TTM net income of TENX is -$14.56 M

What is the all time high TTM net income for Tenax Therapeutics?

Tenax Therapeutics all-time high TTM net profit is -$100.00 K

What is Tenax Therapeutics TTM net income year-on-year change?

Over the past year, TENX TTM net profit has changed by -$4.46 M (-44.13%)